| Company/Division name | West Pharmaceutical Services |
| Parent company | West Pharmaceutical Services |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Total number of jobs (added or to be added): | 90 |
| Year reshoring announced: | 2026 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 90 |
| City reshored to: | Greenfield |
| State(s) reshored to: | IN |
| If relevant, work nearshored to: | - |
| Industry(ies): | Medical Equipment & Supplies |
| Product(s) reshored | self-injection devices, syringe components, seals |
| What domestic positive factors made reshoring more attractive? | Eco-system synergies, Skilled workforce availability/training |
